At the dawn of the social media era, Belle Gibson became a pioneering wellness influencer - telling the world how she beat cancer with an alternative diet. Her bestselling cookbook and online app provided her success, respect, and a connection to the cancer-battling influencer she admired the most. But a curious journalist with a sick wife began asking questions that even those closest to Belle began to wonder. Was the online star faking her cancer and fooling the world? Kaitlyn Dever stars in the Netflix hit series Apple Cider Vinegar . Inspired by true events, the dramatized story follows Belle’s journey from self-styled wellness thought leader to disgraced con artist. It also explores themes of hope and acceptance - and how far we’ll go to maintain it. In this episode of You Can't Make This Up, host Rebecca Lavoie interviews executive producer Samantha Strauss. SPOILER ALERT! If you haven't watched Apple Cider Vinegar yet, make sure to add it to your watch-list before listening on. Listen to more from Netflix Podcasts .…
Player FM - Internet Radio Done Right
Checked 19d ago
เพิ่มแล้วเมื่อ threeปีที่ผ่านมา
เนื้อหาจัดทำโดย Genialis เนื้อหาพอดแคสต์ทั้งหมด รวมถึงตอน กราฟิก และคำอธิบายพอดแคสต์ได้รับการอัปโหลดและจัดหาให้โดยตรงจาก Genialis หรือพันธมิตรแพลตฟอร์มพอดแคสต์ของพวกเขา หากคุณเชื่อว่ามีบุคคลอื่นใช้งานที่มีลิขสิทธิ์ของคุณโดยไม่ได้รับอนุญาต คุณสามารถปฏิบัติตามขั้นตอนที่แสดงไว้ที่นี่ https://th.player.fm/legal
Player FM - แอป Podcast
ออฟไลน์ด้วยแอป Player FM !
ออฟไลน์ด้วยแอป Player FM !
พอดคาสต์ที่ควรค่าแก่การฟัง
สปอนเซอร์
Talking Precision Medicine
ทำเครื่องหมายทั้งหมดว่า (ยังไม่ได้)เล่น…
Manage series 3103485
เนื้อหาจัดทำโดย Genialis เนื้อหาพอดแคสต์ทั้งหมด รวมถึงตอน กราฟิก และคำอธิบายพอดแคสต์ได้รับการอัปโหลดและจัดหาให้โดยตรงจาก Genialis หรือพันธมิตรแพลตฟอร์มพอดแคสต์ของพวกเขา หากคุณเชื่อว่ามีบุคคลอื่นใช้งานที่มีลิขสิทธิ์ของคุณโดยไม่ได้รับอนุญาต คุณสามารถปฏิบัติตามขั้นตอนที่แสดงไว้ที่นี่ https://th.player.fm/legal
Welcome to the Talking Precision Medicine podcast. In this series, we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host.
…
continue reading
42 ตอน
ทำเครื่องหมายทั้งหมดว่า (ยังไม่ได้)เล่น…
Manage series 3103485
เนื้อหาจัดทำโดย Genialis เนื้อหาพอดแคสต์ทั้งหมด รวมถึงตอน กราฟิก และคำอธิบายพอดแคสต์ได้รับการอัปโหลดและจัดหาให้โดยตรงจาก Genialis หรือพันธมิตรแพลตฟอร์มพอดแคสต์ของพวกเขา หากคุณเชื่อว่ามีบุคคลอื่นใช้งานที่มีลิขสิทธิ์ของคุณโดยไม่ได้รับอนุญาต คุณสามารถปฏิบัติตามขั้นตอนที่แสดงไว้ที่นี่ https://th.player.fm/legal
Welcome to the Talking Precision Medicine podcast. In this series, we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host.
…
continue reading
42 ตอน
ทุกตอน
×
1 The journey to the top of life sciences technology: a lifetime of listening and learning | Talking Precision Medicine #42 47:34
Today my guest is Joydeep Goswami , newly appointed President and CEO of the storied biotechnology company LGC. Joydeep is also a strategy advisor to Genialis. Join us as we discuss his remarkable career and lessons learned at each step of the way. Come on in and have a listen. Episode 42 links: TPM E42 for highlights and links from this episode > Tempus Announces a Collaboration With Genialis Genialis’ Upcoming Events…

1 The view from 30,000: Healthcare & life science AI in the cloud | Talking Precision Medicine #41 37:10
This episode features a conversation with Shweta Maniar , who leads the Healthcare and Life Science effort at Google cloud. In just a few short years, artificial intelligence has gone from the stuff of hype and fairy tale to powerful and ubiquitous tools for all aspects of R&D and healthcare delivery. Google has been central to this sea change. I discuss with Shweta how her organization helps make these advanced capabilities available to the masses, and so much more. Join us! Episode 41 links: TPM E41 for highlights and links from this episode > Genialis™ Supermodel Happy Holidays Genialis' Upcoming Events Genialis on LinkedIn…

1 What’s in a digital twin? Inventing new kinds of AI for biomedicine | Talking Precision Medicine #40 47:02
Our guest this episode is Charles Fisher , co-founder and currently Chief Scientific Officer of Unlearn.AI. Unlearn has been a leader in the advancement of Digital Twins as a tool to drastically improve the efficiency of clinical trials. Not only a visionary scientist and trailblazing entrepreneur, Charles is fearless with his hot takes. So sit back and enjoy this free wheeling conversation! Episode 40 links: TPM E40 for highlights and links from this episode > Potential of the Xerna™ TME Panel as a Predictive Biomarker (SITC 2024 Poster) Genialis’ Upcoming Events Genialis on LinkedIn…

1 Leave No Patient Behind—R&D Tools and Cutting Edge Diagnostics that Span the Globe | Talking Precision Medicine #39 35:38
What a genuine pleasure to sit with Thierry Bernard , CEO of Qiagen. As I told Thierry, Qiagen is a truly iconic brand for anyone who came up through molecular biology laboratories in the past 30 years. Their products were ubiquitous, and crucial, to the success of our research. In this conversation, Thierry talks about his global vision for precision medicine, and his mantra that we leave no patient behind. Episode 39 links: TPM E39 for highlights and links from this episode > Genialis™ krasID Poster at 6th Annual RAS-Targeted Drug Development Summit 2024 Genialis’ Upcoming Events Genialis on LinkedIn…
What a pleasure to sit down with my long time colleague and friend, Art Krieg, to discuss his latest venture, Zola Therapeutics, and his adventures in the great outdoors. Art has launched and exited a number of innovative biotechs, each time delving deeper into mechanisms by which we can harness the immune system for therapeutic purposes. Join us as we discuss how — despite a well earned retirement — the siren song that led to Zola was strong enough to get Art back in the game. Episode 38 links: TPM E38 for highlights and links from this episode > Genialis’ Upcoming Events Genialis™ krasID…

1 Cell therapy for T-cell malignancies—the science and business of developing curative medicines for patients in need | Talking Precision Medicine #37 39:01
In this episode I chat with Dr Sarah Hein, co-founder and CEO of March Biosciences, a Houston Based biotech developing cell therapies for T-cell malignancies. Sarah is an old friend and colleague from our days as trainees at Baylor College of Medicine, where we both circulated among those with ambitions of entrepreneurship. Sarah has definitely made good in that regard, as a serial entrepreneur deeply enmeshed in Houston’s growing life sciences and healthtech ecosystem. Episode 37 links: TPM E37 for highlights and links from this episode > Genialis’ Upcoming Events Genialis™ krasID…

1 Tackling healthcare disparities and bridging the digital divide: it doesn’t have to be so hard | Talking Precision Medicine #36 44:13
This episode features two guests, Jennifer Goldsack and Yashoda Sharma , of the Digital Medicine Society, or DiMe. We’re going to get into the nitty gritty of healthcare disparities in terms of access and outcomes, and how digital solutions are a big part of the overall solution. Episode 36 links: TPM E36 for highlights and links from this episode > Genialis’ Upcoming Events Genialis™ krasID…
In this episode Genialis CEO Rafael Rosengarten sat down with Dr. Carolina Haefliger , head of translational medicine at Debiopharm, the privately held Swiss biopharma company focused on oncology drug development. They talked about de-risking promising new cancer drugs, and what it takes from the science to the team to the technologies. Episode 35 links: Visit TPM E35 for highlights and links from this episode > Learn more about Genialis™ krasID > New Genialis RNA Biomarker Accurately Predicts KRAS Outcomes in Lung Cancer Patients >…

1 Professional grade software — a key ingredient in cutting edge biomedical discovery | Talking Precision Medicine #34 31:38
Today we turn the mic around, as our guest Adam Stasio hosts an excellent podcast of his own. Adam’s day job, however, is running SciMed, a boutique life sciences software development company. Adam and Genialis CEO Rafael Rosengarten discuss the state of scientific software, the importance of agility and communication, and approaches to building a lasting company culture. Visit TPM E34 for highlights and links from this episode.…

1 New Medicines from Evolutionary Pathways: Using Comparative Genomics to Treat Human Disease | Talking Precision Medicine #33 42:45
Our guest today is Dr. Ashley Zehnder , co-founder and CEO of Fauna Bio. Fauna is a revolutionary young biotech company using comparative genomics of an array of non-traditional mammalian models to discover new therapeutic opportunities for people. What do ground squirrels have to do with treating battlefield trauma? Only one way to find out … Visit TPM E33 for highlights and links from this episode.…

1 To achieve personalized medicine, start by getting the dose right | Talking Precision Medicine #32 39:13
In this episode, Genialis CEO Rafael Rosengarten sits down with Ajay Gopal, CEO and founder of Rx Studio. Rx Studio is a technology company using data science to tackle a major limitation to personalized medicine: drug dosing. Visit TPM E32 for highlights and links from this episode.
In this episode, Genialis CEO Rafael Rosengarten speaks with BCG management consultant and healthcare innovation expert Amy MacDougall . They discuss emerging trends in healthcare, the role of AI, ethics and more, as well as BCG’s recently released 50 Most Innovative Companies List. Visit TPM E31 for highlights and links from this episode.…

1 People first: building a company that inspires impactful work | Talking Precision Medicine #30 51:06
This episode, Genialis’ thirtieth, is a bit different from the previous ones. CEO Rafael Rosengarten has not one, not two, but three guests, including the entire leadership team at Genialis . The gang discusses Genialis’ twin quests to build a great place to work and a business that makes a positive impact on the world. Visit TPM E30 for highlights and links from this episode.…
Our guest this episode is Dr. Susanna Harris , community lead at Vibe Bio. Susanna is a dedicated scientific communicator and an outspoken advocate for the mental health of PhD students and other science researchers. She has chronicled her journey from the academic lab bench to a venture incubator to a promising biotech company for a substantial social media following, and joins us today to dive into these topics and more. Visit TPM E29 for highlights and links from this episode.…

1 A new way to finance drug development, for rare disease and beyond | Talking Precision Medicine #28 45:36
In this episode, our host and Genialis CEO Rafael Rosengarten spotlights Vibe Bio. Vibe Bio is a new biotech aiming to disrupt how we finance drug development through stakeholder communities and cryptocurrency, starting in the rare disease arena. Our guest is Alok Tayi , co-founder and CEO of Vibe. Alok is a successful serial entrepreneur and a rare disease community member. Visit TPM E28 for highlights and links from this episode.…
T
Talking Precision Medicine

1 What’s in a Name?: Endpoint Health’s Patient-Centric Northstar | Talking Precision Medicine #27 43:16
This episode features Jason Springs, co-founder and CEO of Endpoint Health, an ascendant precision therapeutics company. Jason is a serial entrepreneur, who with the co-founders of his previous company, is building Endpoint Health to bring together under one roof the data science, diagnostics and therapeutics necessary to achieve truly personalized care. Visit TPM E27 for highlights and links from this episode.…
T
Talking Precision Medicine

In this episode 26, our host Rafael sits down with Harry Glorikian . Harry is an investor, author, podcaster and veteran of the healthtech industry. Harry walks us through his latest book, The Future You , and expounds on the ways that wearable devices, personal health data and artificial intelligence are changing healthcare as we know it. Visit TPM E26 for highlights and links from this episode.…
T
Talking Precision Medicine

1 Real-Time Multiplexed Biomarkers: The Next Generation of Continuous Monitoring | Talking Precision Medicine #25 31:47
Earlier this summer, Rafael sat down with Peter Vranes and Hitesh Mehta , co-founders of Nutromics. Nutromics is developing a next generation lab-on-skin, a wearable device for continuous monitoring of health-critical biomarkers. Let’s get right to it. Visit TPM 25 for highlights and links from this episode.…
T
Talking Precision Medicine

Our guest is Dr. Angeli Moeller , Head of Pharma International Informatics at Roche. Angeli and our host, Rafael, discuss data science in the big pharma leagues; geek out on data standards; and dive deep on patient data rights and barriers to care. Visit TPM E24 for highlights and links from this episode.…
T
Talking Precision Medicine

1 From Cancer to Covid, Drug Intelligent Science at Breakneck Pace | Talking Precision Medicine #23 47:19
Our guest for this episode of Talking Precision Medicine is Liang Schweizer from HiFiBiO Therapeutics - one of the most exciting young biotechs out there. They have built a discovery engine encompassing single cell, immune profiling and machine learning. Visit TPM E23 for highlights and links from this episode.…
T
Talking Precision Medicine

1 Ethics and Policies of Precision Medicine on the Global Stage | Talking Precision Medicine #22 49:32
Our guests for this episode of Talking Precision Medicine are Elissa Prichep and Cameron Fox of the World Economic Forum. Elissa and Cameron take us through the W.E.F’s precision medicine initiative, and explain how anticipating ethical tensions is key to envisioning policies for precision medicine across the globe. Visit TPM E22 for highlights and links from this episode.…
T
Talking Precision Medicine

Reboot Rx is a different kind of biotech startup. Reboot’s mission is to find generic non-cancer drugs that can benefit cancer patients quickly and affordably. And as a not-for-profit, Reboot can stay focused on its mission. Given the number of paradigms Reboot hopes to shift at once, we decided to talk with all three co-founders: CEO Laura Kleiman , COO & CTO Pradeep Mangalath and CSO Catherine Del Vecchio Fitz . Each one provides perspective on their part of the puzzle. Visit TPM E21 for highlights and links from this episode.…
T
Talking Precision Medicine

Today Rafael is joined by Dr. Sarma Velamuri , founder and CEO of Luminare. Luminare is a Houston-based digital health company dedicated to ending sepsis—the number 1 cause of death in US hospitals. In the conversation that follows, Dr. Velamuri explains how Luminare saves lives by streamlining hospital workflows, and by changing the behaviors of nurses and doctors. They’ve also made a giant leap into covid tracking, emerging as national leaders on this front. Visit TPM E20 for highlights and links from this episode.…
T
Talking Precision Medicine

Today’s news is dominated by the corona virus and COVID-19 pandemic. Rightfully so. But today we’re bringing you a story of another class of viruses, called Phage. Phage are viruses that find and kill bacteria, and Felix is a Bay Area biotech harnessing the power of phage to fight the scourge of antibiotic resistant infections. So join our conversation with founder and CEO, Dr. Rob McBride, from wherever you have socially distanced yourself or locked down on quarantine, and learn about the viruses that are actually saving lives. Visit TPM E19 for highlights and links from this episode.…
T
Talking Precision Medicine

Today’s episode is a bit different — different in that we are rejoined by a previous guest — David Mittelman . David is CEO of Othram, the first genomics-based forensics company. The audience response to our first conversation was so overwhelming we wanted to have David back on. And the timing couldn’t be better. Since our last chat, David and Othram have been all over the news, and have launched a new database product. Visit TPM E18 for highlights and links from this episode.…
T
Talking Precision Medicine

1 Launching the Hubble Telescope to Cure Cancer with Charlie Silver and Nigel Beard | Talking Precision Medicine #17 38:29
Today our guests are Charlie Silver and Nigel Beard . Charlie is CEO, and Nigel CTO, of Mission Bio. Mission Bio is a single-cell analysis platform company empowering researchers to cure cancer. They are the first company to deliver simultaneous measurement of the genotype and phenotype at single-cell resolution. In this episode, we talk about the audacious mission at Mission Bio, and how their groundbreaking platform enables a whole new set of questions to be answered in cancer research. We also go deep on potential clinical applications and the future of single-cell multi-omic datasets. Visit TPM E17 for highlights and links from this episode.…
T
Talking Precision Medicine

Welcome to the Talking Precision Medicine podcast. In this series, we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host. Genialis is focused on data integration and predictive modeling of disease biology to help accelerate the discovery and de-risk the development of novel therapeutics. Today our guest is Tina Larson. Tina is COO of Recursion Pharmaceuticals, where she is tasked with building the team, the operations and the culture to tackle Recursion’s audacious goals. Tina has over 20 years of experience in the biopharmaceutical industry, and was recently awarded the 2019 Distinguished Alumni Award from her alma mater Colorado State University. In this episode, we talk about the language of multidisciplinary teams, recruiting top talent while fostering inclusivity, and the promise of melding tech and biology to advance treatments at unprecedented scale.…
T
Talking Precision Medicine

Welcome to the Talking Precision Medicine podcast. In this series, we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host. Genialis is focused on data integration and predictive modeling of disease biology to help accelerate the discovery and de-risk the development of novel therapeutics. Today our guest is David Mittelman. David is CEO of Othram, the first genomics-based forensics company. David is also a serial genomics entrepreneur, and, like Genialis, based in Houston. In this episode, David explains his vision for disrupting the state of the art in forensics identification using genomics, deep sequencing and machine learning. A bit of a departure from the usual themes around medical applications of data and data science.…
T
Talking Precision Medicine

1 Garbage in, garbage out? Solve data preprocessing with Gabe Musso | Talking Precision Medicine #14 36:16
Welcome to the Talking Precision Medicine podcast. In this series, we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host. Genialis is focused on data integration and predictive modeling of disease biology to help accelerate the discovery and de-risk the development of novel therapeutics. Today our guest is Gabe Musso. Gabe is Chief Scientific Officer of BioSymetrics, a Toronto-based biomedical AI company empowering healthcare and R&D innovation. In this episode, Gabe tells us how BioSymetrics is working to clean up data clean up, by applying a rigorous product framework to data preprocessing.…
T
Talking Precision Medicine

Welcome to the Talking Precision Medicine podcast. In this series, we sit down with experts on the application of AI and big data analytics in the drug discovery space. Our guests are innovators, business decision makers and thought leaders at the intersection of data and therapeutics. We discuss the promise, practice, challenges, and myths of AI in precision medicine. This show is brought to you by Genialis, and Rafael, our CEO, is your host. Genialis is focused on data integration and predictive modeling of disease biology to help accelerate the discovery and de-risk the development of novel therapeutics. Today our guest is Yusuf Henriques. Yusuf is co-founder and CEO of TruGenomix, a precision medicine company focused on the early detection and prevention of PTSD in military veterans and first responders. In this episode, Yusuf reminds us that every day counts. Because every day there are 20 to 22 veteran suicides. This is what keeps Yusuf up at night, and keeps him pushing on all fronts to innovate a solution.…
ขอต้อนรับสู่ Player FM!
Player FM กำลังหาเว็บ